Cited by 135Pharmacogenetics and Drug MetabolismGenetic Associations and EpidemiologyNutrition, Genetics, and Disease

Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and Projects

Open access
Volpi, Simona, Bult, Carol J., Chisholm, Rex L., Deverka, Patricia A., Ginsburg, Geoffrey S., Jacob, Howard J., Kasapi, Melpomeni, McLeod, Howard L. +24 more·2018·Clinical Pharmacology & Therapeutics

Abstract

Response to a drug often differs widely among individual patients. This variability is frequently observed not only with respect to effective responses but also with adverse drug reactions. Matching patients to the drugs that are most likely to be effective and least likely to cause harm is the goal of effective therapeutics. Pharmacogenomics (PGx) holds the promise of precision medicine through elucidating the genetic determinants responsible for pharmacological outcomes and using them to guide drug selection and dosing. Here we survey the US landscape of research programs in PGx implementation, review current advances and clinical applications of PGx, summarize the obstacles that have hindered PGx implementation, and identify the critical knowledge gaps and possible studies needed to help to address them.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cpt.1048

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Pharmacogenetics roll-out has been hampered by factors including lack of clinical decision support in electronic medical systems.

    “For example, despite multiple examples of clinically important genetic markers related to drug efficacy and side-effect profile145, the roll-out of pharmacogenetics has been hampered by a range of factors, including lack of clinical decision support in electronic medical systems to guide the drug choice or dosing by the physician.”

    From A brief history of human disease genetics (2020) · cites this paper as [145]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [31]UF University of Florida, Precision Medicine Conference < http://precisionmed.pharmacy.ufl.edu/> 2017 Accessed 11/9/2017
  2. [34]NCBI GTR: Genetic Testing Registry < https://www.ncbi.nlm.nih.gov/gtr/all/?term=pharmacogenetic%5Bkeyword%5D> 2017 Accessed 9/12/2017

Cited by

Sorted by citations

Authors
Volpi, S., Bult, C. J., Chisholm, R. L., Deverka, P. A., Ginsburg, G. S., Jacob, H. J., Kasapi, M., McLeod, H. L., Roden, D. M., Williams, M. S., Green, E. D., Rodriguez, L. L., Aronson, S., Cavallari, L. H., Denny, J. C., Dressler, L. G., Johnson, J. A., Klein, T. E., Leeder, J. S., Piquette‐Miller, M., Perera, M., Rasmussen‐Torvik, L. J., Rehm, H. L., Ritchie, M. D., Skaar, T. C., Wagle, N., Weinshilboum, R., Weitzel, K. W., Wildin, R., Wilson, J., Manolio, T. A., & Relling, M. V.
Affiliations
  • National Institutes of Health (US)
  • Jackson Laboratory (US)
  • Northwestern University (US)
  • American Institutes for Research (US)
  • Duke University (US)
  • HudsonAlpha Institute for Biotechnology (US)
  • Moffitt Cancer Center (US)
  • Vanderbilt University Medical Center (US)
  • Geisinger Health System (US)
  • Partners Healthcare Cambridge Massachusetts USA
  • University of Florida (US)
  • Vanderbilt University (US)
  • Mission Health (US)
  • Stanford University (US)
  • Children's Mercy Hospital (US)
  • University of Toronto (CA)
  • Brigham and Women's Hospital (US)
  • University of Pennsylvania (US)
  • Indiana University Indianapolis (US)
  • Dana-Farber Cancer Institute (US)
  • Mayo Clinic (US)
  • University of Florida Health (US)
  • University of Vermont Medical Center (US)
  • Optum (United States) (US)
  • St. Jude Children's Research Hospital (US)
Corresponding author
Volpi, Simona
Venue
Clinical Pharmacology & Therapeutics
Publisher
Wiley
Published
2018-03-30
Volume
103
Issue
5
Pages
778-786
ISSN
  • 0009-9236 (ISSN-L)
  • 1532-6535
OpenAlex
W2793349513
Cited by
135
References
35
Citations by year
2026: 4 · 2025: 7 · 2024: 9 · 2023: 15 · 2022: 27 · 2021: 22 · 2020: 19 · 2019: 22 · 2018: 10
FWCI
3.54
Type
journal article
Language
en
Open access
Locations
  • Clinical Pharmacology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
  • IUScholarWorks (Indiana University) (submittedVersion)
Funders
National Human Genome Research Institute (NIH U01HG007282)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Nutrition, Genetics, and Disease
Keywords
pharmacogenomics, clinical implementation, precision medicine, adverse drug reactions, drug response variability, drug selection, dosage, research programs, knowledge gaps, implementation barriers
MeSH terms
Humans, Pharmacogenetics, Research, United States, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review